icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
Paris France
11-15 April 2018
Back grey_arrow_rt.gif
 
 
 
SVR IS THE STRONGEST PREDICTOR OF OCCURRENCE AND RECURRENCE OF HEPATOCELLULAR CARCINOMA IN HCV CIRRHOTIC PATIENTS AFTER TREATMENT WITH DIRECT ACTING ANTIVIRALS: A PROSPECTIVE MULTICENTER ITALIAN STUDY.
 
 
  Reported by Jules Levin
EASL 2018 April 11-15 Paris France
Session-Clinical impact of HCV cure
 
Ana Lleo, Andrea Aglitti, Alessia Ciancio, Vito Di Marco, Alessio Aghemo, Massimo Colombo, Pietro Lampertco, Maurizia R. Brunetto, Massimo Zuin, Pietro Andreone, Erica Villa, Giulia Troshina, Vincenza Calvaruso, Elisabetta Degasperi, Barbara Coco, Alessia M. Giorgini, Fabio Conti, Alfredo Di Leo, Luca Marzi, Vincenzo Boccaccio, Simona Bollani, Patrick Maisonneuve, Maria Rendina, Marcello Persico, Savino Bruno

0417181

0417182

0417183

0417184

0417185

0417186

0417187

0417188

0417189

04171810